Showing results (231-240 of 248) with videos related to
Sort By:
Pageof 25
BMC Psychiatry|July 6, 2021
Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)Lumbini Azim, Paul Hindmarch, Georgiana Browne, et al.BMJ Open|April 12, 2023
Examining the psychosocial impacts of the COVID-19 pandemic: an international cross-sectional study protocolSandila Tanveer, Philip J Schluter, Richard J Porter, et al.The British Journal of Psychiatry : the Journal of Mental Science|December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definitionDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.BMJ Open|March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocolLumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.Bipolar Disorders|February 17, 2022
Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task ForceKamilla W Miskowiak, Ida Seeberg, Mette B Jensen, et al.Bipolar Disorders|March 4, 2024
Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task ForceKamilla W Miskowiak, Zacharias K Obel, Riccardo Guglielmo, et al.Bipolar Disorders|August 11, 2022
Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task ForceKamilla W Miskowiak, Nefize Yalin, Ida Seeberg, et al.Health Technology Assessment (Winchester, England)|June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trialHamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.Journal of Psychopharmacology (Oxford, England)|January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.Acta Psychiatrica Scandinavica|October 13, 2025
Predicting Response to Pro-Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task ForceDimosthenis Tsapekos, Michail Kalfas, Johanna M Schandorff, et al.Pageof 25